Ammonium chloride, also known as NH4Cl, is a widely used compound in the medical field. It is typically used as a buffer, to neutralize acidity in a solution, and as an electrolyte in medical solutions. It is also used in pharmaceuticals, as a preservative and as a stabilizer. Despite its widespread use, the potential of NH4Cl has yet to be fully explored. This article will explore the potential of NH4Cl, looking at its possible applications in medical treatments and other uses.
NH4Cl is a white, crystalline salt, with a molecular weight of 53.49 g/mol and a density of 1.527 g/cm3. It is highly soluble in water, with a solubility of 1.6 g/100 ml, and is also soluble in alcohols and other organic solvents. It is a weak acid, with a pKa of 9.25, and is readily hydrolyzed in water. It is also hygroscopic, meaning it absorbs moisture from the air.
NH4Cl is used in the medical field for a variety of purposes. It is used as a buffer, to neutralize acidity in a solution, and as an electrolyte in medical solutions. It is also used in pharmaceuticals, as a preservative and as a stabilizer. It is also used in the treatment of certain medical conditions, such as hypokalemia, hyperkalemia, and metabolic acidosis.
Despite its widespread use, the potential of NH4Cl has yet to be fully explored. Research has shown that NH4Cl has potential applications in the medical field, such as in the treatment of cancer, as a wound healing agent, and as an anti-inflammatory agent.
Research has shown that NH4Cl may have potential applications in the treatment of cancer. In one study, NH4Cl was found to inhibit the growth of human breast cancer cells in vitro. In another study, NH4Cl was found to inhibit the growth of human liver cancer cells in vitro. The mechanism of action is not yet clear, but it is thought to involve the inhibition of cell proliferation and the induction of apoptosis.
NH4Cl has also been studied for its potential use as a wound healing agent. In one study, NH4Cl was found to improve wound healing in animal models. The mechanism of action is not yet clear, but it is thought to involve the stimulation of collagen synthesis and the promotion of angiogenesis.
NH4Cl has also been studied for its potential use as an anti-inflammatory agent. In one study, NH4Cl was found to reduce inflammation in animal models. The mechanism of action is not yet clear, but it is thought to involve the inhibition of pro-inflammatory cytokines.
NH4Cl is a widely used compound in the medical field, used as a buffer, electrolyte, preservative, and stabilizer. Despite its widespread use, the potential of NH4Cl has yet to be fully explored. Research has shown that NH4Cl may have potential applications in the medical field, such as in the treatment of cancer, as a wound healing agent, and as an anti-inflammatory agent. Further research is needed to explore the potential of NH4Cl in these and other applications.
1.
Targeted radiation therapy shows near-complete response in rare sarcoma patients
2.
Researchers find distinct cell receptors with the potential for new treatments.
3.
It Is Not Just the Royals Who Go Through Cancer.
4.
Researchers Challenge USPSTF's Lung Cancer Screening Criteria
5.
Prostate cancer screening program beneficial in top decile of polygenic risk score
1.
AI in the War on Cancer: How Digital Tools are Revolutionizing Oncology
2.
Optimizing Chemotherapy Dosing: From Phase 1 Dose Escalation to Modification
3.
Everything You Need to Know About CA 19-9 and Cancer Diagnosis
4.
Unraveling the Mysteries of Lymphoma: A Journey into the Unknown
5.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Navigating the Complexities of Ph Negative ALL - Part I
3.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
5.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation